RICE HALL JAMES & ASSOCIATES, LLC CRNX — CRINETICS PHARMACEUTICALS IN

Ownership history in RICE HALL JAMES & ASSOCIATES, LLC  ·  4 quarters on record

AI Ownership Summary

RICE HALL JAMES & ASSOCIATES, LLC reported CRINETICS PHARMACEUTICALS IN (CRNX) in 4 quarterly 13F filings from 2025 Q3 through 2026 Q2. Peak portfolio weight reached 0.44% in 2025 Q4. The latest visible filing shows CRNX at 0.36% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRNX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was RICE HALL JAMES & ASSOCIATES, LLC's position in CRINETICS PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

CRNX was reported at 0.36% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.44% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRNX stock page RICE HALL JAMES & ASSOCIATES, LLC fund profile RICE HALL JAMES & ASSOCIATES, LLC full holdings
How RICE HALL JAMES & ASSOCIATES, LLC held CRNX — position size vs. price
% of Fund (quarterly)    CRNX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 196,318 +617 +0.3% 0.36% $7.3M 2026-08-07 $83.89
2026 Q1 ADDED — — — 195,701 +23,871 +13.9% 0.40% $7.1M 2026-05-15 $36.77
2025 Q4 REDUCED — — — 171,830 -2,247 -1.3% 0.44% $8.0M 2026-02-17 $43.68
2025 Q3 INITIATED — — — 174,077 — — 0.40% $7.3M 2025-10-16 $42.31

🏢 Other funds also holding CRNX

As of 2026 Q2 — sorted by position size

MOODY ALDRICH PARTNERS LLC 3Y 7Y 0.98% BRAUN STACEY ASSOCIATES INC 3Y 7Y 0.37% Lewis Asset Management, LLC 0.32% AlphaCentric Advisors LLC 3Y 0.31% PSP Research LLC 0.22% FOX RUN MANAGEMENT, L.L.C. 3Y 7Y 0.12% OAK RIDGE INVESTMENTS LLC 3Y 7Y 0.08% Pictet Asset Management Holding SA 0.07% Campbell & CO Investment Adviser LLC 3Y 7Y 0.06% Aberdeen Group plc 3Y 7Y 0.04%

FAQ About RICE HALL JAMES & ASSOCIATES, LLC and CRNX

These are the practical questions this page is built to answer before you even open the full history table.

How long has RICE HALL JAMES & ASSOCIATES, LLC reported owning CRNX?

RICE HALL JAMES & ASSOCIATES, LLC reported CRNX across 4 quarterly 13F filings, from 2025 Q3 through 2026 Q2.

What was the largest reported CRNX position in RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

The largest reported portfolio weight for CRNX was 0.44% in 2025 Q4.

What is the latest reported CRNX position on this page?

The most recent filing on this page is 2026 Q2, when RICE HALL JAMES & ASSOCIATES, LLC reported 196,318 shares, equal to 0.36% of portfolio, with an estimated market value of $7.3M.

What does the chart on this CRNX ownership page compare?

The chart compares RICE HALL JAMES & ASSOCIATES, LLC's quarterly CRNX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did RICE HALL JAMES & ASSOCIATES, LLC time their CRNX position?

Based on 13F filing dates vs. subsequent CRNX price moves, RICE HALL JAMES & ASSOCIATES, LLC correctly timed 3 out of 3 reported position changes (100%). The annualised alpha on CRNX relative to SPY over the holding period was +91.5%.

← Back to RICE HALL JAMES & ASSOCIATES, LLC Holdings